ALLOHA Trademark

Trademark Overview


On Friday, May 24, 2024, a trademark application was filed for ALLOHA with the United States Patent and Trademark Office. The USPTO has given the ALLOHA trademark a serial number of 98568310. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 15, 2025. This trademark is owned by TScan Therapeutics, Inc.. The ALLOHA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical T-cell receptor engineered preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for medical use in the treatment of cancer

Pharmaceutical research and development in the field of T-cell therapy for the treatment of cancer; T-cell therapy research services, namely, pharmaceutical and scientific research in the field of treatment of cancer using T-cell receptor engineered T-cell therapies
alloha

General Information


Serial Number98568310
Word MarkALLOHA
Filing DateFriday, May 24, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements


Goods and ServicesCells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical T-cell receptor engineered preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for medical use in the treatment of cancer
Goods and ServicesPharmaceutical research and development in the field of T-cell therapy for the treatment of cancer; T-cell therapy research services, namely, pharmaceutical and scientific research in the field of treatment of cancer using T-cell receptor engineered T-cell therapies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 24, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTScan Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Party NameTScan Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Friday, May 24, 2024NEW APPLICATION ENTERED
Monday, December 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 9, 2024NON-FINAL ACTION WRITTEN
Monday, December 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 9, 2024NON-FINAL ACTION E-MAILED
Monday, December 9, 2024ASSIGNED TO EXAMINER
Thursday, February 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 21, 2025EXAMINER'S AMENDMENT ENTERED
Friday, March 21, 2025EXAMINERS AMENDMENT E-MAILED
Friday, March 21, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 21, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, March 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 15, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 15, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED